Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial

References

• Baman JR, Ahmad FS. Heart Failure. JAMA. 2020;324(10):1015. doi:10.1001/jama.2020.13310
   PubMedGoogle Scholar
• Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):1757–1780. doi:10.1016/j.jacc.2021.12.011
   PubMed Web of Science ®Google Scholar
• Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–3287. doi:10.1093/cvr/cvac013
   PubMed Web of Science ®Google Scholar
• Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012–2015. Eur J Heart Fail. 2019;21(11):1329–1337. doi:10.1002/ejhf.1629
   PubMed Web of Science ®Google Scholar
• Bragazzi NL, Zhong W, Shu J, et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prevent Cardiol. 2021;28(15):1682–1690. doi:10.1093/eurjpc/zwaa147
   PubMed Web of Science ®Google Scholar
• Park LG, Dracup K, Whooley MA, et al. Sedentary lifestyle associated with mortality in rural patients with heart failure. Eur J Cardiovasc Nurs. 2019;18(4):318–324. doi:10.1177/1474515118822967
   PubMed Web of Science ®Google Scholar
• Groenewegen A, Rutten FH, Mosterd A, et al. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342–1356. doi:10.1002/ejhf.1858
   PubMed Web of Science ®Google Scholar
• Pagliaro BR, Cannata F, Stefanini GG, et al. Myocardial ischemia and coronary disease in heart failure. Heart Fail Rev. 2020;25(1):53–65. doi:10.1007/s10741-019-09831-z
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Rev esp cardiologia. 2022;75(6):523. doi:10.1016/j.rec.2022.05.005
   PubMedGoogle Scholar
• Murphy SP, Ibrahim NE, Januzzi JL. Heart failure with reduced ejection fraction: a review. JAMA. 2020;324(5):488–504. doi:10.1001/jama.2020.10262
   PubMed Web of Science ®Google Scholar
• Boorsma EM, Ter Maaten JM, Damman K, et al. Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol. 2020;17(10):641–655. doi:10.1038/s41569-020-0379-7
   PubMed Web of Science ®Google Scholar
• Liang B, Zhao YX, Zhang XX, et al. Reappraisal on pharmacological and mechanical treatments of heart failure. Cardiovasc Diabetol. 2020;19(1):55. doi:10.1186/s12933-020-01024-5
   PubMed Web of Science ®Google Scholar
• Greene SJ, Fonarow GC, Butler J. Risk profiles in heart failure: baseline, residual, worsening, and advanced heart failure risk. Circulation. 2020;13(6):e007132. doi:10.1161/CIRCHEARTFAILURE.120.007132
   PubMed Web of Science ®Google Scholar
• Liang B, Gu N. Traditional Chinese Medicine for coronary artery disease treatment: clinical evidence from randomized controlled trials. Front Cardiovasc Med. 2021;8:702110. doi:10.3389/fcvm.2021.702110
   PubMed Web of Science ®Google Scholar
• Mao J, Zhang J, Lam CSP, et al. Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial. ESC Heart Fail. 2020;7(6):3881–3890. doi:10.1002/ehf2.12980
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yu J, Zhang W, et al. An integrated evidence-based targeting strategy for determining combinatorial bioactive ingredients of a compound herbal medicine Qishen Yiqi dripping pills. J Ethnopharmacol. 2018;219:288–298. doi:10.1016/j.jep.2018.02.041
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiography. 2005;18(12):1440–1463. doi:10.1016/j.echo.2005.10.005
   PubMed Web of Science ®Google Scholar
• Liang B, Qu Y, Zhao QF, et al. Guanxin V for coronary artery disease: a retrospective study. Biomed Pharmacother. 2020;128:110280. doi:10.1016/j.biopha.2020.110280
   PubMed Web of Science ®Google Scholar
• Wang H, Chai K, Du M, et al. Prevalence and incidence of heart failure among urban patients in China: a national population-based analysis. Circulation. 2021;14(10):e008406. doi:10.1161/CIRCHEARTFAILURE.121.008406
   PubMed Web of Science ®Google Scholar
• Wang H, Li L, Qing X, et al. Efficacy of Qishen Yiqi Drop Pill for chronic heart failure: an updated meta-analysis of 85 studies. Cardiovasc Ther. 2020;2020:8138764. doi:10.1155/2020/8138764
   PubMed Web of Science ®Google Scholar
• Giannitsi S, Bougiakli M, Bechlioulis A, et al. 6-minute walking test: a useful tool in the management of heart failure patients. Therap Adv Cardiovasc Dis. 2019;13:1753944719870084. doi:10.1177/1753944719870084
   Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975. doi:10.1002/ejhf.592
   PubMed Web of Science ®Google Scholar
• Salah K, Stienen S, Pinto YM, et al. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Heart. 2019;105(15):1182–1189. doi:10.1136/heartjnl-2018-314173
   PubMed Web of Science ®Google Scholar